SOFTOX WOUND & SKIN CARE AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: IJ
Ingrid Juven1969
Chairman of the board: HJ
Henrik Johannes Nielsen1953
Years since formation: 7 years; since Nov 22, 2018
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 400; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Total operating income 2023: 30,265; NOK
Annual total result 2023: -8,369,371; NOK
Total equity 2023: -17,695,995; NOK

Last update: Jan 22, 2025

Management

Management / administration

Name	Role	Shares
IJ Ingrid Juven 1969	Managing Director/CEO	-

Board

Name	Role	Shares
HJ Henrik Johannes Nielsen 1953	Chairman	-
KA Kristian Almås 1956	Board Member	11.49 % indirectly
LJ Lars Johan Frigstad 1964	Board Member	-

Others

Name	Role	Shares
B BERGE & LUNDAL REVISJONSSELSKAP AS	Auditor	-
E ECIT INTUNOR AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
KA Kristian Almås 1956	Board Member	11.49 % indirectly
GA Geir Hermod Almås 1964	-	7.86 % indirectly
ST Sjur Thorsheim 1958	-	3.41 % indirectly
GH Gunnar Heglund 1939	-	2.89 % indirectly
DA Dina Kristine Aa Almås 1996	-	1.96 % indirectly
CS Claus Seeberg 1965	-	1.83 % indirectly
BH Bjørn Herness 1966	-	1.75 % indirectly
OO Ottar Olsen 1970	-	1.52 % indirectly
PH Per Haug 1949	-	1.42 % indirectly
YA Yuliya Almås 1980	-	1.28 % indirectly

Last update: Jan 22, 2025

Ownership

Company shareholders

Name	Share class	Number of shares	Share
S SOFTOX SOLUTIONS AS	Ordinary shares	400	100 %

Last update: May 24, 2024

Group structure

SOFTOX SOLUTIONS AS
Total operating income 2023: NOK 2,185,793
Operating profit 2023: NOK -41,967,859
Employees: 0

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	30,265	129,825	1,881,932
Annual Total Result	-8,369,371	-2,516,688	-5,398,382
Total assets	243,032	7,276,024	7,681,160
Total liabilities	17,939,028	16,602,649	14,491,096
Total equity	-17,695,995	-9,326,624	-6,809,936

P&L

Year	2023	2022	2021
Total operating income	30,265	129,825	1,881,932
Total operating costs	4,630,820	3,356,347	8,748,777
Operating result	-4,600,555	-3,226,522	-6,866,845
Financial income/costs	-1,560	0	-54,162
Profit before tax	-4,602,115	-3,226,522	-6,921,007
Total tax & extraordinary income/cost	3,767,256	-709,834	-1,522,625
Annual Total Result	-8,369,371	-2,516,688	-5,398,382

Balance overview

Year	2023	2022	2021
Total fixed assets	219,836	6,212,349	5,827,772
Total current assets	23,197	1,063,675	1,853,388
Total assets	243,032	7,276,024	7,681,160
Short term debt	17,939,028	16,602,649	43,540
Long term debt	0	0	14,447,556
Total liabilities	17,939,028	16,602,649	14,491,096
Contributed capital	4,030,000	4,030,000	4,030,000
Retained earnings	-21,725,995	-13,356,624	-10,839,936
Total equity	-17,695,995	-9,326,624	-6,809,936
Total equity and liabilities	243,032	7,276,024	7,681,160

SOFTOX WOUND & SKIN CARE AS921 773 668